Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Bausch & Lomb Corp (BLCO)
Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Bausch + Lomb and Novaliq Announce Publication of Second Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in American Journal of Ophthalmology Business Wire - Wed Mar 22, 6:00AM CDT

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Novaliq GmbH, a biopharmaceutical company...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results Business Wire - Wed Feb 22, 5:59AM CST

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023 Business Wire - Wed Feb 15, 5:58AM CST

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, announced the appointment...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
New Bausch + Lomb Social Media Campaign Highlights What ‘Sights’ Inspire AMD Patients Business Wire - Tue Feb 7, 6:00AM CST

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced a new social media campaign...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection) Business Wire - Wed Feb 1, 6:00AM CST

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Modulight Corporation (“Modulight”),...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22 Business Wire - Mon Jan 23, 6:00AM CST

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Acquires AcuFocus, Inc. Business Wire - Tue Jan 17, 4:09PM CST

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc. (“AcuFocus”), a privately...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™ Business Wire - Mon Jan 9, 7:00AM CST

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference Business Wire - Mon Jan 9, 6:00AM CST

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, has published a company...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference Business Wire - Thu Jan 5, 6:00AM CST

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)

Barchart Exclusives

The X-Factor that Could Trigger a Gold Boom in the 2nd Half of 2023 Barchart - Wed Mar 29, 5:15PM CDT
Gold prices jumped to $2,000 last week in the wake of the collapse of Silicon Valley Bank. However, this could be just the start of a higher move for the precious metal. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot